IRIS
BELLOTTI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.626
EU - Europa 3.402
AS - Asia 2.396
SA - Sud America 8
AF - Africa 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.449
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.606
CN - Cina 2.228
IE - Irlanda 1.106
UA - Ucraina 596
FI - Finlandia 491
DE - Germania 320
IT - Italia 281
SE - Svezia 248
GB - Regno Unito 180
SG - Singapore 102
FR - Francia 88
BE - Belgio 34
IN - India 27
CA - Canada 19
CZ - Repubblica Ceca 8
JP - Giappone 8
NL - Olanda 8
IR - Iran 7
RU - Federazione Russa 7
MU - Mauritius 6
RO - Romania 5
BR - Brasile 4
HK - Hong Kong 4
HU - Ungheria 4
PL - Polonia 4
TR - Turchia 4
AU - Australia 3
GR - Grecia 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
KR - Corea 2
LK - Sri Lanka 2
LT - Lituania 2
MD - Moldavia 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
ES - Italia 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
MX - Messico 1
PK - Pakistan 1
PT - Portogallo 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 10.449
Salva come PNG Salva come JPEG
Città #
Dublin 1.105
Chandler 1.033
Jacksonville 752
Nanjing 659
Boardman 316
Nanchang 276
Ashburn 267
Beijing 235
Princeton 222
Wilmington 200
Shenyang 199
Hebei 185
Lawrence 184
Ann Arbor 176
Changsha 162
Medford 154
Helsinki 146
Jiaxing 135
Tianjin 97
Hangzhou 91
Woodbridge 75
Milan 70
Shanghai 70
Singapore 58
New York 47
Pavia 41
Falls Church 40
Verona 40
Brussels 34
Norwalk 30
Piscataway 27
Fairfield 22
Los Angeles 17
Jinan 16
Auburn Hills 15
Seattle 14
Toronto 14
Kunming 11
Ningbo 11
Washington 11
Chicago 10
Houston 9
Guangzhou 7
Zhengzhou 7
Chandigarh 6
Dallas 6
Fuzhou 6
Padova 6
Taizhou 6
Brno 5
Dearborn 5
Hefei 5
Lanzhou 5
London 5
Orange 5
Redmond 5
Tappahannock 5
Budapest 4
Des Moines 4
Formia 4
Hanover 4
Redwood City 4
Rome 4
Saint Albans 4
San Francisco 4
San Giuliano Milanese 4
Tokyo 4
Berlin 3
Boston 3
Campina Grande 3
Catania 3
Changchun 3
Hong Kong 3
Leawood 3
Munich 3
Pune 3
Rockville 3
Santa Clara 3
Zanjan 3
Andover 2
Arlington 2
Ban Kho 2
Bari 2
Belgrade 2
Birmingham 2
Bologna 2
Borås 2
Brescia 2
Brunswick 2
Bucharest 2
Cardito 2
Castino 2
Chisinau 2
Colombo 2
Deiva Marina 2
Falkenstein 2
Feldthurns 2
Genova 2
Groningen 2
Hyderabad 2
Totale 7.478
Salva come PNG Salva come JPEG
Nome #
L'ipotesi della cascata amiloide nella malattia di Alzheimer: studi su strategie di neuroprotezione. 150
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 110
Hepatitis C virus-associated cryoglobulinaemicglomerulonephritis with delayed appearance of monoclonal cryoglobulinaemia. 96
C. elegans expressing human beta2-microglobulin: a novel model for studying the relationship between the molecular assembly and the toxic phenotype. 92
WALDENSTROM'S HYPERGLOBULINEMIC PURPURA IN HLA IDENTICAL SISTERS. 91
A specific nanobody prevents amyloidogenesis of D76N β2-microglobulin in vitro and modifies its tissue distribution in vivo 89
D-strand perturbation and amyloid propensity in beta-2 microglobulin. 87
The H50Q mutation induces a tenfold decrease in the solubility of α-synuclein. 86
Biological activity and pathological implications of misfolded proteins. 84
Search of ligands for the amyloidogenic protein beta(2)-microglobulin by capillary electrophoresis and other techniques 84
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 82
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 81
Beta 2- microglobulin can be refolded into a native state from ex vivo amyloid fibrils 78
AMYLOIDOSIS AL 78
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits. 78
Identification and characterization of a new ligand-binding site in FnbB, a fibronectin-binding adhesin from Streptococcus dysgalactiae 77
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis 77
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. 76
CHRONIC LYMPHOCYTIC LEUKAEMIA OR IDIOPATHIC COLD HAEMAGGLUTININ DISEASE? A DILEMMA RAISED BY AN ERRONEOUS ELECTRONIC CELL COUNT 75
USE OF A MONOCLONAL ANTIBODY AGAINST HUMAN HEART FERRITIN FOR EVALUATING ACIDIC FERRITIN CONCENTRATION IN HUMAN SERUM 75
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy 75
Sulfonated molecules that bind a partially structured species of beta2-microglobulin also influence refolding and fibrillogenesis. 74
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 73
Heparin strongly enhances the formation of beta 2-microglobulin amyloid fibrils in the presence of type I collagen 72
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 71
AN INTERLEUKIN 2 BINDING FACTOR IN HUMAN SERUM 69
DE loop mutations affect beta2-microglobulin stability and amyloid aggregation 69
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 69
Capillary electrophoresis studies on the aggregation process of beta-amyloid 1-42 and 1-40 peptides 68
“Separation and quantification of two beta2-microglobulin isoforms”. 68
Use of an anti-idiotypic monoclonal antibody in studying amyloidogenic light chains in cells, urine and fibrils: pathophysiology and clinical implications. 68
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 68
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 67
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 67
Capillary electrophoresis investigation of a partially unfolded conformation of Beta 2-microglobulin. 67
Collagen plays an active role in the aggregation of beta 2-microglobulin under physio-pathological conditions of dialysis-related amyloidosis. 66
beta 2-microglobulin H31Y variant 3D-structure highlights the protein natural propensity towards intermolecular aggregation 66
Anatomic and Clinical Clues to in vivo mechanisms of amyloidogenesis. in , (2005) vol. 1, pp.29-48. 66
Class I Major Histocompatibility Complex, the Trojan horse for secretion of amyloidogenic β2-microglobulin. 66
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 66
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 64
Conformational transition and cellular toxicity by amyloidogenic proteins 63
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 63
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 63
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 63
Topological investigation of amyloid fibrils obtained from beta2-microglobulin 63
Proteomics of beta2-microglobulin amyloid fibrils. 63
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 63
Atomic structure of a nanobody trapped domain swapped dimer of an amyloidogenic β2-microglobulin variant 63
Reversal of nephrotic syndrome due to reactive amyloidosis (AA-type) after excision of localized Castleman's disease. 63
Cinetiche di refolding e studi di affinità mediante elettroforesi capillare: effetto di ligandi di interesse farmaceutico sulla conformazione della Beta 2-microglobulina 63
The potential of capillary electrophoresis in the study of amyloidoses 62
PLASMA FERRITIN DETERMINATION AS A DIAGNOSTIC TOOL 62
Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin 62
The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. 61
{beta}2-microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity. 61
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 60
Solution structure of beta(2)-microglobulin and insights into fibrillogenesis 60
Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases. 60
Biochimica Applicata 60
Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of β2-microglobulin 60
Co-fibrillogenesis of Wild-type and D76N β2-Microglobulin: THE CRUCIAL ROLE OF FIBRILLAR SEEDS 60
SELECTIVE BONE MARROW INVOLVMENT OF LYMPHOPLASMACYTIC CELLS SECRETING MONOCLONAL IGA RHEUMATOID FACTOR IN A PATIENT WITH SJORGREN'S SYNDROME AND SERUM HYPERVISCOSITY. 59
Nanobodies against beta2-microglobulin. 59
Studies on neuroprotective strategy based on the amyloid cascade hypothesis 59
Current concepts on the pathogenisis of systemic amyloidosis 58
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 58
A recurrent D-strand association interface is observed in β-2 microglobulin oligomers. 58
Cerebrospinal fluid ferritin in human disease. 58
Enhanced toxicity of silver nanoparticles in transgenic Caenorhabditis elegans expressing amyloidogenic proteins 58
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 58
Fibrillogenesis of human beta2-microglobulin in three-dimensional silicon microstructures 58
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 57
Towards understanding the molecular pathogenesis of monoclonal immunoglobulin light-chain deposition 56
Lysozyme: A paradigmatic molecule for the investigation of protein structure, function and misfolding 56
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 56
Effect of tetracyclines on the dynamics of formation and destructuration of {beta}2-microglobulin amyloid fibrils. 56
Dynamic of beta(2)-microglobulin fibril formation and reabsorption: the role of proteolysis. 55
Preliminary crystallographic characterization of the human beta2 microglobulin His31Tyr mutant in a tetrameric assembly. 55
Folding intermediates and transient oligomers: difficult protein targets to find new drugs for amyloidoses 55
Protein Aggregation 55
Clinical evaluation of erythrocyte zinc-protoporphyrin as a parameter of iron status in man. 55
Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis 55
Lysozyme 54
Enhanced molecular chaperone activity of the small heat-shock protein αB-crystallin following covalent immobilization onto a solid-phase support. 54
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 54
An Asp to Asn mutation is a toxic trigger in beta-2 microglobulin: structure and biophysics 54
Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel. 54
Conformational dynamics of the beta2-microglobulin C terminal in the cell-membrane-anchored major histocompatibility complex type I 54
Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a "protein misfolding disease". REVIEW ARTICLE 53
The two tryptophans of β2-microglobulin have distinct roles in function and folding and might represent two independent responses to evolutionary pressure. 53
Gene expression of pyrogenic cytokines in Hodgkin's disease lymph nodes. 53
Neurodegenerative diseases caused by protein aggregation: a phenomenon at the borderline between molecular evolution and ageing. 53
IMMUNOCHEMICAL CHARACTERISTICS OF A PARTICULAR CRYOGLOBULIN. A NEW CRYOGLOBULIN SUBGROUP? 53
Development of a method to screen potential ligands of amyloidogenic proteins 53
Antiamyloidogenic and proamyloidogenic chaperone effects of C-reactive protein and serum amyloid P component 53
Plasminogen activation triggers transthyretin amyloidogenesis in vitro 53
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 53
Characterization of apo(a) polymorphism by a modified immunoblotting techniques in an Italian population sample 52
Bifunctional crosslinking ligands for transthyretin 52
Totale 6.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.625
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.625
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020757 0 0 0 112 12 113 23 125 3 212 146 11
2020/20211.154 156 101 31 111 11 161 8 183 49 167 144 32
2021/2022905 15 7 11 13 28 56 18 64 58 36 132 467
2022/20233.045 365 239 26 219 315 280 0 160 1.307 20 64 50
2023/2024968 136 202 40 57 104 222 12 48 8 41 69 29
2024/2025392 71 240 78 3 0 0 0 0 0 0 0 0
Totale 10.684